Escalon Medical Corp. (OTCMKTS:ESMC) Sees Large Decrease in Short Interest

Escalon Medical Corp. (OTCMKTS:ESMC) was the target of a large decline in short interest during the month of May. As of May 29th, there was short interest totaling 83,822 shares, a decline of 51.0% from the May 14th total of 171,227 shares. Based on an average trading volume of 89,881 shares, the days-to-cover ratio is presently 0.9 days. Currently, 1.2% of the shares of the stock are short sold.

Escalon Medical Stock Up 1.4%

OTCMKTS ESMC opened at $0.20 on Friday. The stock has a 50 day moving average price of $0.19 and a 200-day moving average price of $0.18. Escalon Medical has a one year low of $0.10 and a one year high of $0.42. The company has a market capitalization of $1.47 million, a P/E ratio of 1.80 and a beta of 0.14. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.94 and a current ratio of 2.59.

Escalon Medical (OTCMKTS:ESMC) last issued its quarterly earnings data on Friday, May 15th. The medical equipment provider reported $0.16 EPS for the quarter. The business had revenue of $2.61 million during the quarter. Escalon Medical had a net margin of 16.17% and a negative return on equity of 21.42%.

Escalon Medical Company Profile

Escalon Medical Corp. engages in the development, manufacturing, marketing, and distribution of medical devices and pharmaceuticals in the area of ophthalmology in the United States and internationally. It offers A-Scan, which provides information about the internal structure of the eye; B-Scan, a diagnostic tool that supplies information to physicians where the media within the eye are cloudy or opaque; UBM, a high frequency/high resolution ultrasound device, which provides detailed information about the anterior segment of the eye; and Pachymeter that measures the thickness of cornea.